Literature DB >> 31361892

Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction.

Yan Wang1,2, Shuai Li1,2, Zhenyu Tian1,2, Jiaqi Sun1,2, Shuobin Liang1,2, Bo Zhang3, Lu Bai1,2, Yuanjie Zhang1,2, Xueying Zhou1,2, Sulong Xiao1,2, Qiang Zhang1,4, Lihe Zhang1, Chuanling Zhang1,2, Demin Zhou1,2.   

Abstract

Application of viral vectors in gene delivery is attracting widespread attention but is hampered by the absence of control over transduction, which may lead to non-selective transduction with adverse side effects. To overcome some of these limitations, we proposed an unnatural amino acid aided caging-uncaging strategy for controlling the transduction capability of a viral vector. In this proof-of-principle study, we first expanded the genetic code of the lentiviral vector to incorporate an azido-containing unnatural amino acid (Nϵ-2-azidoethyloxycarbonyl-l-lysine, NAEK) site specifically within a lentiviral envelope protein. Screening of the resultant vectors indicated that NAEK incorporation at Y77 and Y116 was capable of inactivating viral transduction upon click conjugation with a photo-cleavable chemical molecule (T1). Exposure of the chimeric viral vector (Y77-T1) to UVA light subsequently removed the photo-caging group and restored the transduction capability of lentiviral vector both in vitro and in vivo. Our results indicate that the use of the photo-uncage activation procedure can reverse deactivated lentiviral vectors and thus enable regulation of viral transduction in a switchable manner. The methods presented here may be a general approach for generating various switchable vectors that respond to different stimulations and adapt to different viral vectors.
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2019        PMID: 31361892      PMCID: PMC6821241          DOI: 10.1093/nar/gkz659

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Photolabile precursors of cyclic nucleotides with high aqueous solubility and stability.

Authors:  Lijuan Wang; John E T Corrie; John F Wootton
Journal:  J Org Chem       Date:  2002-05-17       Impact factor: 4.354

Review 2.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

3.  Precise Photoremovable Perturbation of a Virus-Host Interaction.

Authors:  Sarah B Erickson; Raja Mukherjee; Rachel E Kelemen; Chester J J Wrobel; Xiaofu Cao; Abhishek Chatterjee
Journal:  Angew Chem Int Ed Engl       Date:  2017-03-15       Impact factor: 15.336

Review 4.  CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.

Authors:  Shannon L Maude; David T Teachey; David L Porter; Stephan A Grupp
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 5.  Gene therapy comes of age.

Authors:  Cynthia E Dunbar; Katherine A High; J Keith Joung; Donald B Kohn; Keiya Ozawa; Michel Sadelain
Journal:  Science       Date:  2018-01-12       Impact factor: 47.728

Review 6.  Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C.

Authors:  Kunkai Su; Dan Wang; Jian Ye; Yun C Kim; Samson A Chow
Journal:  Methods       Date:  2009-01-30       Impact factor: 3.608

Review 7.  Chimeric antigen receptor T-cell therapies for lymphoma.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Nat Rev Clin Oncol       Date:  2017-08-31       Impact factor: 66.675

Review 8.  Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes.

Authors:  Annika M Frank; Christian J Buchholz
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-17       Impact factor: 6.698

Review 9.  Photodynamic Efficiency: From Molecular Photochemistry to Cell Death.

Authors:  Isabel O L Bacellar; Tayana M Tsubone; Christiane Pavani; Mauricio S Baptista
Journal:  Int J Mol Sci       Date:  2015-08-31       Impact factor: 5.923

Review 10.  Gene therapy: progress and predictions.

Authors:  Mary Collins; Adrian Thrasher
Journal:  Proc Biol Sci       Date:  2015-12-22       Impact factor: 5.349

View more
  4 in total

Review 1.  Viral vector platforms within the gene therapy landscape.

Authors:  Jote T Bulcha; Yi Wang; Hong Ma; Phillip W L Tai; Guangping Gao
Journal:  Signal Transduct Target Ther       Date:  2021-02-08

2.  Integrase deficient lentiviral vector: prospects for safe clinical applications.

Authors:  Chee-Hong Takahiro Yew; Narmatha Gurumoorthy; Fazlina Nordin; Gee Jun Tye; Wan Safwani Wan Kamarul Zaman; Jun Jie Tan; Min Hwei Ng
Journal:  PeerJ       Date:  2022-08-12       Impact factor: 3.061

Review 3.  Current Progress of CAR-NK Therapy in Cancer Treatment.

Authors:  Zhaojun Pang; Zhongyi Wang; Fengqi Li; Chunjing Feng; Xin Mu
Journal:  Cancers (Basel)       Date:  2022-09-02       Impact factor: 6.575

4.  Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors.

Authors:  Maximilian Hörner; Carolina Jerez-Longres; Anna Hudek; Sebastian Hook; O Sascha Yousefi; Wolfgang W A Schamel; Cindy Hörner; Matias D Zurbriggen; Haifeng Ye; Hanna J Wagner; Wilfried Weber
Journal:  Sci Adv       Date:  2021-06-16       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.